Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04422639 · ClinicalTrials.gov registry record · NA
Preoperative SRS/SRT vs Postoperative SRS/SRT for Brain Metastases
A NA study, sponsored by University of Arkansas.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04422639 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 3 participants.
The verdict
NCT04422639, a NA study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This pilot study is a randomized, open-label, 2-arm active-controlled phase II clinical trial conducted at a single study site (UAMS). Subjects will be randomized to one of the 2 treatment arms and stratified by size of index lesion and number of brain metastases. The investigators will prospectively compare preoperative (neoadjuvant) SRS/SRT to postoperative (adjuvant) SRS/SRT in patients undergoing surgical resection for brain metastases. The investigators hypothesize that neoadjuvant SRS/SRT prior to surgical resection of brain metastases will result in improved freedom from Central Nervous System (CNS) events when compared to adjuvant SRS/SRT after surgical resection.
Interventions
- RADIATION SRS/SRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-08-24 |
| Est. Completion | 2023-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04422639
The ClinicalTrials.gov registry entry for NCT04422639 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SRS/SRT is the first listed.
NCT04422639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04422639 about?
NCT04422639 is a clinical study titled "Preoperative SRS/SRT vs Postoperative SRS/SRT for Brain Metastases". This pilot study is a randomized, open-label, 2-arm active-controlled phase II clinical trial conducted at a single study site (UAMS). Subjects will be randomized to one of the 2 treatment arms and stratified by size of index lesion and number of brain metastases. The investigators will prospective...
What is the current status of trial NCT04422639?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2020-08-24. Estimated completion is 2023-03-27.
What interventions are being tested in trial NCT04422639?
The interventions under investigation include: SRS/SRT (RADIATION).
Who is sponsoring clinical trial NCT04422639?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.